Abstract

Vancomycin-resistant enterococci are a global challenge currently as reported by the World Health Organization. It is also important to recognize that combating antimicrobial resistance needs to recognize the interconnections between people, animals, plants and their shared environment in creating public health, the so-called One Health approach. Although the presence of VRE has been described in many regions of the world, there is a lack of comprehensive data indicating their prevalence of in Africa. Therefore, this study aimed to aggregate the result of studies describing VRE reported across multiple regions in Africa. A literature search was conducted on PubMed, Google scholar, and Hinari with the term “Vancomycin resistance enterococcus in Africa” on August 1–3, 2019. All available articles were downloaded to “Endnote version 7.1” then to Microsoft Word 2013. Articles determined to meet our criteria for the review was extracted to Microsoft Excel 2013. Those articles that reported the prevalence of vancomycin resistance Enterococcus obtained from all sample types and published from 2010 to 2019 in the English language were included for the review. A meta-analysis was conducted with OpenMetaAnalyst version R.3.1.0 software. The effect size was determined using a binary random effect model and statically significant considered when p < 0.05. Heterogeneity determined with the inconsistency index. A leave one out analysis used to perform the sensitivity analysis. There were 151 articles identified from the database searches; of this, 36 articles included after extensive review with two independent authors. Out of 4073 samples collected, 1488 isolates identified with an overall pooled prevalence of VRE 26.8% (95% CI; 10.7–43.0%) in Africa with a one-health perspective. The analysis showed that considerable heterogeneity among the studies (I2 = 99.97%; p < 0.001). Subgroup analysis in-country, African region, laboratory method, year of publication, and sample source showed that a high prevalence was identified from South Africa (74.8%), South African regions (74.8%), PCR (959.2%), 2010–2015 years (30.3%) and environmental (52.2%), respectively. This meta-analysis indicates that there was a high-pooled prevalence of vancomycin-resistant enterococci in African. A lot should be done to prevent and control the transmission of vancomycin resistance enterococci to a human being from the environment in the continent.

Highlights

  • Vancomycin-resistant enterococci are a global challenge currently as reported by the World Health Organization

  • The subgroup analysis performed based on country indicates that the highest prevalence of VRE was in South Africa 74.8% observed followed by, Egypt 37.2%, Uganda 9.8%, Morocco 8.2%, Ethiopia 7.9%, Tunisia 6.5%, Tanzania 6.1%, Nigeria 2.8% and Algeria 2.8%

  • The strength of our review and meta-analysis is, it presented an all-inclusive data about VRE in Africa. It offered a subgroup analysis of data based on country, laboratory method used, African regions, year of publication, and source of the sample

Read more

Summary

Introduction

Vancomycin-resistant enterococci are a global challenge currently as reported by the World Health Organization. Articles determined to meet our criteria for the review was extracted to Microsoft Excel 2013 Those articles that reported the prevalence of vancomycin resistance Enterococcus obtained from all sample types and published from 2010 to 2019 in the English language were included for the review. Subgroup analysis in-country, African region, laboratory method, year of publication, and sample source showed that a high prevalence was identified from South Africa (74.8%), South African regions (74.8%), PCR (959.2%), 2010–2015 years (30.3%) and environmental (52.2%), respectively This meta-analysis indicates that there was a high-pooled prevalence of vancomycin-resistant enterococci in African. Intrinsic resistance occurs in isolates of E. gallinarum and E. casseliflavus /E. flavescens, which demonstrate an innate, low-level resistance to vancomycin These enterococci rarely cause infections in humans or animals. Whole-genome sequencing data suggest that VRE might have evolved from ampicillin-resistant E. feacium from d­ ogs[9]

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call